ENTEROME ENTEROME
  • COMPANY
    • FOCUS
    • COLLABORATIONS
    • LEADERSHIP
  • TECHNOLOGY
    • PROGRAMS & PRODUCTS
  • PIPELINE
  • INVESTORS
  • NEWSROOM
    • PRESS RELEASES
    • CONFERENCES & EVENTS
  • CAREERS
  • CONTACT
ENTEROME ENTEROME
  • COMPANY
    • FOCUS
    • COLLABORATIONS
    • LEADERSHIP
  • TECHNOLOGY
    • PROGRAMS & PRODUCTS
  • PIPELINE
  • INVESTORS
  • NEWSROOM
    • PRESS RELEASES
    • CONFERENCES & EVENTS
  • CAREERS
  • CONTACT
Sep 19 2016

Enterome appoints Christophe Bonny as Chief Scientific Officer

Paris, France and Cambridge, MA, USA – September 19, 2016

Enterome Bioscience SA (“Enterome”), a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, is pleased to announce that it has appointed Christophe Bonny, Ph.D. as Chief Scientific Officer (CSO). Dr. Bonny, will be responsible for developing and advancing Enterome’s R&D strategy focused on the identification of novel targets derived from the microbiome, and the development of molecules secreted by the gut microbiome that mediate interactions with the host – and not mixtures of bacterial strains – as potential new therapeutics.

Dr. Bonny joins Enterome with 20 years’ of medical research and industry experience with a strong background in drug discovery and pre-clinical development in the areas of inflammatory diseases and oncology. He was previously CSO at Bicycle Therapeutics in the UK and before that he worked at Switzerland-based Xigen where he served as CSO and President. Prior to Xigen, Dr. Bonny was Head of Research of the Medical Genetics Unit at the University Hospital of Lausanne, Switzerland. He obtained a Ph.D. in molecular biology from the University of Neuchâtel, Switzerland, and completed a business and entrepreneurship program at Babson College, US. Dr. Bonny is an author on over 100 scientific publications and is an inventor on multiple patents.

“Enterome has an exceptional opportunity to become a leading company developing innovative drugs and diagnostics based on its unrivalled understanding of the microbiome. In just a short time, Enterome has shown the power of its technology and is advancing its lead product, EB8018, which acts on a novel target in Crohn’s Disease. I am excited to join the Company at a time of significant momentum and I look forward to working to further develop and advance Enterome’s pipeline based on its world-class technologies and capabilities,” said Christophe Bonny, Ph.D.

“At Enterome, we are taking a radically different approach from other microbiome companies to pin down well-defined novel targets and develop small molecules and diagnostic products based on our technology platform. We are very pleased to welcome Dr. Bonny to Enterome and l am sure he will make an important contribution as we look to build a pipeline of novel therapeutic products based on our ‘drugs from bugs’ approach,” said Pierre Belichard, CEO of Enterome. “Enterome is at an important inflexion point as we look to leverage our technology, knowledge and industry partnerships to become one of the leading microbiome companies globally.”

PR_Enterome_Cambridge_Office-1

 

 

> Read the Press Release

 

Comments are closed.

Categories

  • PRESS RELEASES
  • PRESS RELEASES 2020
  • PRESS RELEASES 2019
  • PRESS RELEASES 2018
  • PRESS RELEASES 2017
  • PRESS RELEASES 2016
  • PRESS RELEASES 2015
  • PRESS RELEASES 2014
  • CAREERS
  • PRESS
ETEROME-Bioscience

ENTEROME

94/96 avenue Ledru-Rollin
75011 PARIS, FRANCE
Tel : +33 (0)1 75 77 27 85
Email : info@enterome.com

INFORMATIONS

RCS Paris N° 508 580 289
Siret : 50858028900025
NAF : 7211Z
N° TVA : FR40 508 580 289

Legal notice • Privacy Policy • Cookie Policy
2021 ENTEROME — All rights reserved.
Lors de votre navigation sur notre site internet, nous sommes susceptibles de déposer des cookies sur votre appareil à des fins d’analyses et de performances. Vous avez la possibilité d’accepter, de refuser ou de paramétrer le dépôt de cookies.

When you navigate on our website, we may deposit cookies on your device for analysis and performance purposes. You are able to accept, refuse or configure the cookies' deposit. [ Read More ]

Cookie settings Reject Accept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience. Read more about our Privacy Policy.
Necessary
Always Enabled

The cookies defines under this category are absolutely essential for the website to function. Hence they are loaded by default irrespective if user consent.

CookieDescription
cookielawinfo-checkbox-necessaryThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-non-necessaryThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Non Necessary".
PHPSESSIDThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policyThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Analytics

Analytics cookies help us understand how our visitors interact with the website. It helps us understand the number of visitors, where the visitors are coming from, and the pages they navigate. The cookies collect this data and are reported anonymously.

CookieDescription
_gaThis cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, camapign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assigns a randoly generated number to identify unique visitors.
_gidThis cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form.

Performance

These cookies collect information about how visitors use a website, for instance which pages visitors go to most often, and if they get error messages from web pages. These cookies don’t collect information that identifies a visitor. All information these cookies collect is aggregated and therefore anonymous. It is only used to improve how a website works.

CookieDescription
_gatThis cookies is installed by Google Universal Analytics to throttle the request rate to limit the colllection of data on high traffic sites.